USAN Modifies Lead Drug Candidate’s Chemical Name to ‘Simufilam’
Future References to Lead Drug Candidate for Alzheimer’s Disease Will Be Simufilam AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) --...
Year: 2020
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights
– R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable...
Spectral Medical to Host Virtual Investor Day on December 4, 2020
TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused...
DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
Initial funding of up to $34 million for the project “Gene Mabs: A Scalable, Economic, Gene-Encoded Protective Antibody Platform Against...
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S. Biogen to...
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
IMCIVREE™(setmelanotide) Logo Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™(setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity...
Nexstim Plc provides an update on the pilot study in severe depression at Kuopio University Hospital
Company announcement, Inside information, Helsinki, 27 November 2020 at 14.00 (EET) Nexstim Plc provides an update on the pilot study...
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with anemia of CKD not...
Policy thought-leaders, Don Drummond and Duncan Sinclair, release long-term care report seeking to reshape the future for Canadian seniors
KINGSTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Today, renowned public policy experts Don Drummond and Duncan Sinclair released a...
Braingrid Limited Announces Changes to Board of Directors
TORONTO, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”) is pleased to announce that...
EXMceuticals Provides Bi-Weekly Default Status Report
VANCOUVER, British Columbia, Nov. 26, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) is...
ECMOHO to Announce Third Quarter 2020 Unaudited Financial Results
SHANGHAI, China, Nov. 27, 2020 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions...
Saniona AB’s Nomination Committee for the Annual General Meeting 2021
PRESS RELEASE November 26, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the...
Kane Biotech Announces Third Quarter 2020 Financial Results
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
Eve & Co Announces Financial Results for the Three and Nine Months Ended September 30, 2020
STRATHROY, Ontario, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE;...
On “Grindeks” results in the first nine months of 2020
On “Grindeks” results in the first nine months of 2020 “Grindeks” turnover increases by 29%, profit by 36% in the first nine...
Hologic to Showcase Products Across Breast Cancer Screening, Biopsy, Surgery and Treatment at Virtual RSNA 2020
Leader in women’s health, first in prestigious IMV rankings, to host innovative digital product experiences and medical education sessions MARLBOROUGH,...
StageZero Life Sciences Announces Filing of Reviewed Q3 Statements
TORONTO, ON / ACCESSWIRE / November 26, 2020 / StageZero Life Sciences Ltd. (TSX:SZLS) ("StageZero", or the "Company") announces that...
CureVac to Report Third Quarter and First Nine Months 2020 Financial Results and Business Updates on November 30, 2020
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 26, 2020 / CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a...